Activity of daily life dependency predicts the risk of mortality in patients with COVID-19 undergoing hemodialysis: a retrospective analysis of a single center with nosocomial outbreak.

Activities of daily life dependency COVID-19 Hemodialysis Nosocomial outbreak

Journal

Renal replacement therapy
ISSN: 2059-1381
Titre abrégé: Ren Replace Ther
Pays: England
ID NLM: 101698599

Informations de publication

Date de publication:
2022
Historique:
received: 07 03 2022
accepted: 26 08 2022
entrez: 14 9 2022
pubmed: 15 9 2022
medline: 15 9 2022
Statut: ppublish

Résumé

We experienced a nosocomial outbreak of coronavirus disease 2019 (COVID-19) from November 2020 to February 2021, during the third wave of the pandemic in Japan. We retrospectively assessed the characteristics and data of 20 inpatients undergoing hemodialysis who were hospitalized for treatment of diseases other than COVID-19 during the COVID-19 nosocomial outbreak ("inpatient," IP), and of 10 outpatients undergoing hemodialysis who were hospitalized for the care of COVID-19 under outpatient visits ("outpatient," OP). Eleven patients in the IP group (55%) and one in the OP group (10%) died. Kaplan-Meier analysis showed that the IP group died more rapidly than the OP group ( Our findings show that the nosocomial infected group has a worse prognosis, although it is not an independent predictor for the risk of mortality. ADL dependency could predict the risk of mortality in all hemodialysis patients with COVID-19 during the third wave pandemic in Japan.

Sections du résumé

Background UNASSIGNED
We experienced a nosocomial outbreak of coronavirus disease 2019 (COVID-19) from November 2020 to February 2021, during the third wave of the pandemic in Japan.
Methods UNASSIGNED
We retrospectively assessed the characteristics and data of 20 inpatients undergoing hemodialysis who were hospitalized for treatment of diseases other than COVID-19 during the COVID-19 nosocomial outbreak ("inpatient," IP), and of 10 outpatients undergoing hemodialysis who were hospitalized for the care of COVID-19 under outpatient visits ("outpatient," OP).
Results UNASSIGNED
Eleven patients in the IP group (55%) and one in the OP group (10%) died. Kaplan-Meier analysis showed that the IP group died more rapidly than the OP group (
Conclusion UNASSIGNED
Our findings show that the nosocomial infected group has a worse prognosis, although it is not an independent predictor for the risk of mortality. ADL dependency could predict the risk of mortality in all hemodialysis patients with COVID-19 during the third wave pandemic in Japan.

Identifiants

pubmed: 36101873
doi: 10.1186/s41100-022-00434-3
pii: 434
pmc: PMC9458297
doi:

Types de publication

Journal Article

Langues

eng

Pagination

47

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

JAMA Netw Open. 2021 Apr 1;4(4):e216556
pubmed: 33830226
EClinicalMedicine. 2021 May 23;36:100896
pubmed: 34036252
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Int J Environ Res Public Health. 2021 Jul 29;18(15):
pubmed: 34360333
Ther Apher Dial. 2020 Aug;24(4):361-365
pubmed: 32506762
Kidney Int. 2002 Dec;62(6):2238-45
pubmed: 12427151
J Am Geriatr Soc. 2012 Aug;60(8):1478-86
pubmed: 22861118
Am J Kidney Dis. 2016 Feb;67(2):283-92
pubmed: 26612280
Clin J Am Soc Nephrol. 2021 Aug;16(8):1237-1246
pubmed: 34074636
J Am Soc Nephrol. 2020 Jul;31(7):1409-1415
pubmed: 32467113
BMC Nephrol. 2016 Jul 08;17(1):72
pubmed: 27391964
Intensive Care Med. 2020 Apr;46(4):579-582
pubmed: 32103284
J Am Geriatr Soc. 2013 Sep;61(9):1537-51
pubmed: 24028357
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Kidney Blood Press Res. 2021;46(2):250-256
pubmed: 33774645
Am J Kidney Dis. 2021 May;77(5):748-756.e1
pubmed: 33465417
Infect Control Hosp Epidemiol. 2021 Jun;42(6):746-750
pubmed: 33115548
Md State Med J. 1965 Feb;14:61-5
pubmed: 14258950
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Clin Exp Nephrol. 2021 Jun;25(6):652-659
pubmed: 33555454
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
PLoS One. 2020 Aug 14;15(8):e0237692
pubmed: 32797094
Semin Dial. 2022 Jan;35(1):71-80
pubmed: 34137080
Int Urol Nephrol. 2021 Jan;53(1):177-184
pubmed: 32797384
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
J Med Virol. 2021 Apr;93(4):2141-2148
pubmed: 33090527
N Engl J Med. 2009 Oct 15;361(16):1539-47
pubmed: 19828531
Lancet Public Health. 2020 Aug;5(8):e444-e451
pubmed: 32619408
Research (Wash D C). 2020 Apr 19;2020:2402961
pubmed: 32377638
JAMA Netw Open. 2020 Dec 1;3(12):e2029058
pubmed: 33301018
Kidney Int. 2000 Oct;58(4):1758-64
pubmed: 11012910
Kidney Int Rep. 2021 Mar;6(3):586-593
pubmed: 33354635
J Am Soc Nephrol. 2020 Jul;31(7):1387-1397
pubmed: 32385130
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447
pubmed: 32667668
Ren Replace Ther. 2021;7(1):59
pubmed: 34697570
Clin Infect Dis. 2021 Dec 6;73(11):e3677-e3689
pubmed: 32986793
J Infect. 2020 Nov;81(5):e3-e5
pubmed: 32920063
J Am Soc Nephrol. 2004 Apr;15(4):1038-45
pubmed: 15034107
Kidney Int. 2020 Jul;98(1):20-26
pubmed: 32437768
J Clin Med. 2020 Jul 04;9(7):
pubmed: 32635468
Lancet. 2018 May 5;391(10132):1775-1782
pubmed: 29706364
Semin Dial. 2021 Jan;34(1):57-65
pubmed: 33118200
Open Forum Infect Dis. 2020 Oct 22;7(12):ofaa512
pubmed: 33330740

Auteurs

Jun Ino (J)

Department of Nephrology, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Fumika Iemura (F)

Department of Nephrology, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Chihiro Nakajima (C)

Department of Nephrology, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Mio Kodama (M)

Department of Nephrology, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Saeko Kumon (S)

Department of Nephrology, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Keitaro Sato (K)

Department of Nephrology, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Hitoshi Eizumi (H)

Department of Nephrology, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Nobuhiro Hijikata (N)

Department of Cardiovascular Medicine, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Sadayuki Oshio (S)

Department of Emergency Medicine, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Shingo Tachibana (S)

Department of Surgery, Toda Central General Hospital, 1-19-3 Hon-cho, Toda City, Saitama 335-0023 Japan.

Kosaku Nitta (K)

Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjyuku-ku, Tokyo 162-0054 Japan.

Junichi Hoshino (J)

Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjyuku-ku, Tokyo 162-0054 Japan.

Classifications MeSH